期刊
MOLECULAR AND CELLULAR ENDOCRINOLOGY
卷 242, 期 1-2, 页码 96-102出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2005.08.005
关键词
PPAR gamma; PPAR gamma ligand; SRC-1; 3T3-L1; ChIP assay; anti-inflammation
Based on the binding between peroxisome proliferators-activated receptor gamma (PPAR-gamma) and steroid receptor co-activator-1 (SRC-1), an enzyme-linked immunosorbent assay (ELISA) was used to screen new PPAR-gamma ligands from various benzylidinethiazole derivatives, which have anti-inflammatory activity. Among those derivatives, 5-(3,5-di-tert-butyl-4-hydroxybenzylidene) thiazolidine-2,4-dione (BTZD) increased the binding between PPAR-gamma and SRC-1. BTZD was found to induce adipogenesis and PPAR-gamma trans-activation in 3T3-L1 pre-adipocyte, and increased the binding between PPAR-gamma and SRC-1 in in vitro binding assay and complex consisting of PPAR-gamma and SRC-1 in the co-immunoprecipitaion. Chromatin immunoprecipitation (ChIP) analysis revealed that BTZD induced the binding of PPAR-gamma-SRC-1 complex to PPAR response element (PPRE) in the same pattern of other PPAR-gamma ligand. From these studies, we have identified and studied the function of a new PPAR-gamma ligand, BTZD. We suggest that BTZD can be used as a modulator of PPAR-gamma. This study applying ELISA and ChIP assay can offer new methods to screen PPAR gamma ligand and understand the effects of PPAR-gamma ligands on inflammation. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据